60%–80% of anaplastic astrocytoma contains homozygous deletion, mutation, and promoter hypermethylation of the INK4A/ARF locus, and 25% of anaplastic oligodendrogliomas have hypermethylation of the INK4A/ARF locus [2]. Here, CDKN2A is linked to anaplastic oligodendroglioma.